Study for Novel Coronavirus Pneumonia (NCP)

Novel Coronavirus Pneumonia Clinical Trial

Official title:

Study for Clinical Epidemiology and Methods of Diagnosis and Treatment of Novel Coronavirus Pneumonia (NCP)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04283396
• Other study ID #: NCP01
• Status: Recruiting
• Start date: February 21, 2020
• Est. completion date: July 30, 2020

Study information

• Verified date: March 2020
• Source: Wuhan Union Hospital, China
• Contact: Yang Jin
• Phone: 13554361146
• Email: whunjy[@]126.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To develop practical and effective clinical diagnosis and treatment schemes for the control of novel coronavirus pneumonia.

Description:

By retrospectively analyzing the clinical epidemiological characteristics of the novel coronavirus pneumonia and the current diagnosis and treatment schemes, as well as in-depth analyzing the disease development process and outcome trends of NCP patients to develop practical and effective clinical diagnosis and treatment schemes and provide guarantee for the rapid control of the epidemic.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 2000
• Est. completion date: July 30, 2020
• Est. primary completion date: May 30, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• Patients confirmed with novel coronavirus pneumonia. The Diagnostic criteria refer to "Pneumonitis Diagnosis and Treatment Scheme for Novel Coronavirus Infection (Trial Version 5)";

Exclusion Criteria:

• Physician judged the patient was not suitable for this clinical trial.

Related Conditions & MeSH terms

• Coronavirus Infections
• Novel Coronavirus Pneumonia
• Pneumonia

Intervention

Combination Product:
• systemic treatment
Oxygen therapy, antiviral therapy, antibiotics, hormones, globulin

Locations

Country	Name	City	State
China	Union hospital	Wuhan	Hubei

Sponsors (1)

Lead Sponsor	Collaborator
Wuhan Union Hospital, China

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	recovery	Number of patients recover from novel coronavirus pneumonia	up to 24 weeks